| Potential repurposed drug candidates for tuberculosis treatment: progress and update of drugs identified in over a decade K Sharma, F Ahmed, T Sharma, A Grover, M Agarwal, S Grover ACS omega 8 (20), 17362-17380, 2023 | 26 | 2023 |
| Regulation of Plasmodium falciparum Origin Recognition Complex subunit 1 (PfORC1) function through phosphorylation mediated by CDK‐like kinase PK5 AS Deshmukh, M Agarwal, P Mehra, A Gupta, N Gupta, CD Doerig, ... Molecular microbiology 98 (1), 17-33, 2015 | 26 | 2015 |
| Epigenetic code during mycobacterial infections: therapeutic implications for tuberculosis S Fatima, A Kumari, M Agarwal, I Pahuja, V Yadav, VP Dwivedi, ... The FEBS Journal 289 (14), 4172-4191, 2022 | 20 | 2022 |
| Berberine governs NOTCH3/AKT signaling to enrich lung-resident memory T cells during tuberculosis I Pahuja, K Negi, A Kumari, M Agarwal, S Mukhopadhyay, B Mathew, ... PLoS Pathogens 19 (3), e1011165, 2023 | 19 | 2023 |
| The bifunctional protein GlmU is a key factor in biofilm formation induced by alkylating stress in Mycobacterium smegmatis A Di Somma, M Caterino, V Soni, M Agarwal, P di Pasquale, S Zanetti, ... Research in microbiology 170 (4-5), 171-181, 2019 | 19 | 2019 |
| Identification and characterization of ARS‐like sequences as putative origin(s) of replication in human malaria parasite Plasmodium falciparum M Agarwal, K Bhowmick, K Shah, A Krishnamachari, SK Dhar The FEBS Journal 284 (16), 2674-2695, 2017 | 15 | 2017 |
| Role of Chromatin assembly factor 1 in DNA replication of Plasmodiumáfalciparum MK Gupta, M Agarawal, K Banu, KS Reddy, D Gaur, SK Dhar Biochemical and biophysical research communications 495 (1), 1285-1291, 2018 | 10 | 2018 |
| Regulation of DNA replication proteins in parasitic protozoans: possible role of CDK-like kinases AS Deshmukh, M Agarwal, SK Dhar Current genetics 62, 481-486, 2016 | 10 | 2016 |
| Combating the challenges of COVID-19 pandemic: Insights into molecular mechanisms, immune responses and therapeutics against SARS-CoV-2 K Negi, M Agarwal, I Pahuja, B Bhardwaj, M Rawat, A Bhaskar, ... Oxford Open Immunology 4 (1), iqad001, 2023 | 9 | 2023 |
| Withaferin A protects against primary and recurrent tuberculosis by modulating Mycobacterium-specific host immune responses A Kumari, I Pahuja, K Negi, A Ghoshal, S Mukopadhyay, M Agarwal, ... Microbiology Spectrum 11 (2), e00583-23, 2023 | 7 | 2023 |
| Atosiban and Rutin exhibit anti-mycobacterial activity-An integrated computational and biophysical insight toward drug repurposing strategy against Mycobacterium tuberculosis … R Sharma, SA Muthu, M Agarwal, NK Mehto, I Pahuja, A Grover, ... International Journal of Biological Macromolecules 253, 127208, 2023 | 6 | 2023 |
| Unique C-terminal extension and interactome of Mycobacterium tuberculosis GlmU impacts its in vivo function and the survival of the pathogen M Agarwal, V Soni, S Kumar, B Singha, VK Nandicoori Biochemical Journal 478 (11), 2081-2099, 2021 | 5 | 2021 |
| Unravelling the potential of Triflusal as an anti-TB repurposed drug by targeting replication protein DciA W Ali, S Jamal, R Gangwar, F Ahmed, I Pahuja, R Sharma, VP Dwivedi, ... Microbes and Infection 26 (3), 105284, 2024 | 1 | 2024 |
| Essential mycobacterial gene glmM as an immunotherapeutic target against tuberculosis V Nandicoori, M Agarwal, VP Dwivedi, A Bhaskar, B Singha, A Singh, ... | | 2023 |
| Structure-based drug repurposing to inhibit the replication-associated essential protein DnaG of Mycobacterium tuberculosis. W Ali, S Jamal, R Gangwar, F Ahmed, M Agarwal, JA Sheikh, S Grover | | 2023 |
| DNA, DNA Replication, and Aging B Sharma, M Agarwal, V Verma, SK Dhar Models, Molecules and Mechanisms in Biogerontology: Cellular Processes …, 2020 | | 2020 |
